Neringa Zadeikis

778 total citations
9 papers, 579 citations indexed

About

Neringa Zadeikis is a scholar working on Epidemiology, Pharmacology and Molecular Medicine. According to data from OpenAlex, Neringa Zadeikis has authored 9 papers receiving a total of 579 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Epidemiology, 4 papers in Pharmacology and 4 papers in Molecular Medicine. Recurrent topics in Neringa Zadeikis's work include Pneumonia and Respiratory Infections (6 papers), Antibiotic Resistance in Bacteria (4 papers) and Antibiotics Pharmacokinetics and Efficacy (4 papers). Neringa Zadeikis is often cited by papers focused on Pneumonia and Respiratory Infections (6 papers), Antibiotic Resistance in Bacteria (4 papers) and Antibiotics Pharmacokinetics and Efficacy (4 papers). Neringa Zadeikis collaborates with scholars based in United States. Neringa Zadeikis's co-authors include Alan M. Tennenberg, Mohammed M. Khashab, Jim Xiang, James B. Kahn, Lala M. Dunbar, Barbara A. Wiesinger, Richard G. Wunderink, Michael P. Habib, Leon G. Smith and Shu‐Chen Wu and has published in prestigious journals such as Clinical Infectious Diseases, CHEST Journal and The Journal of Urology.

In The Last Decade

Neringa Zadeikis

9 papers receiving 557 citations

Peers

Countries citing papers authored by Neringa Zadeikis

Since Specialization

Citations

This map shows the geographic impact of Neringa Zadeikis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Neringa Zadeikis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Neringa Zadeikis more than expected).

Fields of papers citing papers by Neringa Zadeikis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Neringa Zadeikis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Neringa Zadeikis. The network helps show where Neringa Zadeikis may publish in the future.

Co-authorship network of co-authors of Neringa Zadeikis

This figure shows the co-authorship network connecting the top 25 collaborators of Neringa Zadeikis. A scholar is included among the top collaborators of Neringa Zadeikis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Neringa Zadeikis. Neringa Zadeikis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

#	Work	Indexed citations
1	Levofloxacin for Treatment of Ventilator-Associated Pneumonia: A Subgroup Analysis from a Randomized Trial 2005 ·Clinical Infectious Diseases ·Andrew F. Shorr, Neringa Zadeikis, William L. Jackson, (unknown), Shu-Chen Wu, Alan M. Tennenberg, Marin H. Kollef	26
2	A multicenter, randomized, double-blind, retrospective comparison of 5- and 10-day regimens of levofloxacin in a subgroup of patients aged ≥65 years with community-acquired pneumonia 2005 ·Clinical Therapeutics ·Andrew F. Shorr, Neringa Zadeikis, Jim Xiang, Alan M. Tennenberg, E. Wes Ely	35
3	110: Clinical Significance of Anti-Microbial Therapy in Chronic Prostatitis Associated with Nontraditional Uropathogens 2005 ·The Journal of Urology ·J. Curtis Nickel, Neringa Zadeikis, (unknown), Shu‐Chen Wu	9
4	Levofloxacin Efficacy in the Treatment of Community-Acquired Legionellosis 2004 ·CHEST Journal ·Victor L. Yu, Richard N. Greenberg, Neringa Zadeikis, Janet E. Stout, Mohammed M. Khashab, William H. Olson, Alan M. Tennenberg	71
5	Clinical implications of 750 mg, 5-day levofloxacin for the treatment of community-acquired pneumonia 2004 ·Current Medical Research and Opinion ·Thomas M. File, Gary Milkovich, Alan M. Tennenberg, Jim Xiang, Mohammed M. Khashab, Neringa Zadeikis	26
6	Efficacy of 750-mg, 5-day levofloxacin in the treatment of community-acquired pneumonia caused by atypical pathogens 2004 ·Current Medical Research and Opinion ·Lala M. Dunbar, Mohammed M. Khashab, James B. Kahn, Neringa Zadeikis, Jim Xiang, Alan M. Tennenberg	68
7	Levofloxacin versus ciprofloxacin in the treatment of chronic bacterial prostatitis: a randomized double-blind multicenter study 2003 ·Urology ·(unknown), (unknown), Paul S. Ray, William M. Schiff, Alan M. Tennenberg, Barbara A. Wiesinger, Pamela A. Wright, Shu‐Chen Wu, Neringa Zadeikis, James B. Kahn	92
8	High‐Dose, Short‐Course Levofloxacin for Community‐Acquired Pneumonia: A New Treatment Paradigm 2003 ·Clinical Infectious Diseases ·Lala M. Dunbar, Richard G. Wunderink, Michael P. Habib, Leon G. Smith, Alan M. Tennenberg, Mohammed M. Khashab, Barbara A. Wiesinger, Jim Xiang, Neringa Zadeikis, James B. Kahn	250
9	Comparative Study of Infectious Complications of Different Types of Chronic Central Venous Access Devices 1995 ·Infectious Diseases in Clinical Practice ·Neringa Zadeikis	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact